Jun 2026 (Q2 FY26) — Aug 5, 2026
KORU Q2 FY26 — Record Revenue, Positive Net Income, and Strategic Technology Acquisition
Read the full callKORU (KRMD) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
KORU earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 12.0 | +18.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 5.2 | +8.3 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 0.25 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$3.02 +0.67% · +$0.02
Performance −25.4% 1Y
1Y: $4.05 on 17 Oct 2025 → $3.02. High $6.52 (23 Dec 2025), low $2.93 (30 Sept 2026).
- Previous close
- $3
- 52-week range
- $2.93 – $6.52
- One year
- −27.05%
Overview
- Symbol
- KRMD
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
KORU earnings calls (KRMD)
Financials
What the filings say
Net profit, year on year: +222% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 8 | 9 | 10 | 10 | 10 | 11 | 12 | 12 |
| Operating profit | -2 | -2 | -1 | -0 | -1 | -1 | -1 | 1 |
| Operating margin | −20.8% | −18.0% | −12.9% | −3.1% | −8.3% | −5.0% | −7.3% | 5.2% |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Profit before tax | -2 | -2 | -1 | -0 | -1 | -0 | -1 | 0 |
| Tax rate | — | — | — | −9.2% | 0.0% | −1.0% | — | 2.3% |
| Net profit | -2 | -2 | -1 | -0 | -1 | -0 | -1 | 0 |
| EPS ($ per share) | -0.03 | — | -0.03 | 0 | — | — | -0.02 | 0.01 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 4 | 5 | 4 | -1 | -10 | -23 | -29 | -32 |
| Total liabilities | 2 | 3 | 4 | 5 | 11 | 8 | 10 | 11 |
| Fixed assets | 1 | 1 | 1 | 1 | 4 | 4 | 4 | 4 |
| Total assets | 11 | 14 | 40 | 41 | 42 | 28 | 27 | 28 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1 | 0 | -1 | -4 | -5 | -5 | -0 | 0 |
| Cash from investing | -2 | 1 | -1 | -0 | -3 | -1 | -1 | -1 |
| Cash from financing | 0 | 1 | 23 | 3 | 0 | -0 | -0 | -0 |
| Net cash flow | — | — | 21 | -2 | -8 | -6 | -2 | -1 |
| Capital expenditure | -0 | -0 | -1 | -0 | -3 | -1 | -1 | -1 |
| Free cash flow | 1 | 0 | -2 | -5 | -8 | -6 | -2 | -0 |
Insider filings
53 filings between Nov 26, 2025 and Oct 1, 2026.
Open market
decisions to buy or sellPurchases
$215.3K
8 purchases by 5 insiders
Sales
None
No insider sold shares.
Compensation
not trading decisions- 25
- Award — granted as compensation
- 7
- Option exercise — converted options into shares
- 7
- Tax withheld — shares kept back by the company to cover tax
Also filed: 5 other filings, 1 gift.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| KALBERMATTEN ADAM R | $150.4K | — | Sep 8, 2026 |
| Adams Thomas Edward | $21.2K | — | May 14, 2026 |
| Schiller Eric | $19.6K | — | May 18, 2026 |
| Pazdan Christopher | $19.4K | — | May 14, 2026 |
| Tharby Linda M | $4.7K | — | May 15, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | WHOLIHAN EDWARD Director | Award | 5,119 | $15.0K |
| Oct 1, 2026 | French Donna Director | Award | 5,119 | $15.0K |
| Oct 1, 2026 | CASCELLA ROBERT Director | Award | 5,119 | $15.0K |
| Oct 1, 2026 | Matin Shahriar Director | Award | 5,119 | $15.0K |
| Oct 1, 2026 | FLETCHER R JOHN Director | Award | 7,679 | $22.5K |
| Sep 30, 2026 | Manko Joseph M. Jr. Director | Award | 5,119 | $0 |
| Sep 8, 2026 | KALBERMATTEN ADAM R Chief Commercial Officer | Purchase | 32,000 | $101.1K |
| Jul 28, 2026 | KALBERMATTEN ADAM R Chief Commercial Officer | Option exercise | 75,000 | $0 |
| Jul 28, 2026 | KALBERMATTEN ADAM R Chief Commercial Officer | Tax withheld | 25,483 | $108.6K |
| Jul 1, 2026 | Matin Shahriar Director | Award | 3,571 | $15.0K |
| Jul 1, 2026 | French Donna Director | Award | 3,571 | $15.0K |
| Jul 1, 2026 | FLETCHER R JOHN Director | Award | 5,357 | $22.5K |
| Jul 1, 2026 | WHOLIHAN EDWARD Director | Award | 3,571 | $15.0K |
| Jul 1, 2026 | CASCELLA ROBERT Director | Award | 3,571 | $15.0K |
| Jun 30, 2026 | Manko Joseph M. Jr. Director | Award | 3,571 | $0 |
| Jun 11, 2026 | KALBERMATTEN ADAM R President-Chief Commercial Off | Purchase | 7,500 | $29.5K |
| Jun 11, 2026 | KALBERMATTEN ADAM R President-Chief Commercial Off | Purchase | 5,000 | $19.8K |
| May 18, 2026 | Schiller Eric Chief Technology Officer | Purchase | 5,000 | $19.6K |
| May 15, 2026 | Tharby Linda M Chief Executive Officer | Purchase | 1,191 | $4.7K |
| May 14, 2026 | Tharby Linda M Chief Executive Officer | Tax withheld | 7,326 | $28.9K |
| May 14, 2026 | Tharby Linda M Chief Executive Officer | Option exercise | 13,977 | $0 |
| May 14, 2026 | Adams Thomas Edward Chief Financial Officer | Tax withheld | 2,900 | $11.4K |
| May 14, 2026 | Pazdan Christopher Chief Operating Officer | Tax withheld | 1,470 | $5.8K |
| May 14, 2026 | Pazdan Christopher Chief Operating Officer | Purchase | 5,000 | $19.4K |
| May 14, 2026 | Pazdan Christopher Chief Operating Officer | Option exercise | 5,327 | $0 |
| May 14, 2026 | Adams Thomas Edward Chief Financial Officer | Option exercise | 8,193 | $0 |
| May 14, 2026 | Adams Thomas Edward Chief Financial Officer | Purchase | 459 | $1.8K |
| May 14, 2026 | Adams Thomas Edward Chief Financial Officer | Purchase | 5,041 | $19.5K |
| Apr 1, 2026 | FLETCHER R JOHN Director | Award | 5,208 | $22.5K |
| Apr 1, 2026 | WHOLIHAN EDWARD Director | Award | 3,472 | $15.0K |
| Apr 1, 2026 | Matin Shahriar Director | Award | 3,472 | $15.0K |
| Apr 1, 2026 | French Donna Director | Award | 3,472 | $15.0K |
| Apr 1, 2026 | CASCELLA ROBERT Director | Award | 3,472 | $15.0K |
| Mar 31, 2026 | Manko Joseph M. Jr. Director | Award | 3,472 | $0 |
| Mar 16, 2026 | Adams Thomas Edward Chief Financial Officer | Option exercise | 5,404 | $0 |
| Mar 16, 2026 | Tharby Linda M Chief Executive Officer | Tax withheld | 5,756 | $24.6K |
| Mar 16, 2026 | Tharby Linda M Chief Executive Officer | Option exercise | 15,968 | $0 |
| Mar 16, 2026 | Pazdan Christopher Chief Operating Officer | Tax withheld | 1,628 | $7.0K |
| Mar 16, 2026 | Pazdan Christopher Chief Operating Officer | Option exercise | 5,064 | $0 |
| Mar 16, 2026 | Adams Thomas Edward Chief Financial Officer | Tax withheld | 2,123 | $9.1K |
| Feb 13, 2026 | Manko Joseph M. Jr. Director | Other | 282,347 | $0 |
| Feb 13, 2026 | Manko Joseph M. Jr. Director | Other | 750,000 | $0 |
| Feb 13, 2026 | Manko Joseph M. Jr. Director | Other | 750,000 | $0 |
| Feb 13, 2026 | Manko Joseph M. Jr. Director | Other | 770,418 | $0 |
| Jan 2, 2026 | Schiller Eric Chief Technology Officer | Award | 76,426 | $0 |
| Jan 2, 2026 | Matin Shahriar Director | Award | 2,581 | $15.0K |
| Jan 2, 2026 | CASCELLA ROBERT Director | Award | 2,581 | $15.0K |
| Jan 2, 2026 | WHOLIHAN EDWARD Director | Award | 2,581 | $15.0K |
| Jan 2, 2026 | French Donna Director | Award | 2,581 | $15.0K |
| Jan 2, 2026 | FLETCHER R JOHN Director | Award | 3,872 | $22.5K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for KORU Medical Systems, Inc.
Free account. Everything above stays public.
Write why you follow KORU Medical Systems, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading